Clinical Trials Logo

Lymphedema clinical trials

View clinical trials related to Lymphedema.

Filter by:

NCT ID: NCT04779450 Recruiting - Breast Cancer Clinical Trials

Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors

Start date: August 1, 2021
Phase: N/A
Study type: Interventional

The objective of the study is to evaluate the effectiveness of telemonitoring in the dysfunctions of the upper limbs in activities of daily living, quality of life and prevention of lymphedema in women undergoing treatment for breast cancer. Secondarily, to analyze the degree of satisfaction in the proposed treatment modality. This is a randomized controlled trial, double blind (evaluator and patient), parallel in three groups (synchronous telemonitoring group, asynchronous telemonitoring group and control group). The protocol will last six weeks, and quality of life, upper limb functionality, and risk of lymphedema will be evaluated. Both intervention groups will be submitted to a kinesiotherapy program three times a week, with synchronous and asynchronous monitoring, while the control group will receive usual post cancer orientations. Kinesiotherapy protocol in synchronous form compared to the usual recommendations in remote form is expected to show superior result in upper limb function and quality of life of women after breast cancer.

NCT ID: NCT04766489 Completed - Breast Cancer Clinical Trials

Evaluation of the Treatment Response in Breast Cancer Related Lymphedema

Start date: July 11, 2019
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of the treatment for breast cancer lymphedema. After taking a detailed history and giving a physical examination, breast cancer related lymphedema patients(n:30) will be informed and will be given Complete Decongestive Therapy, which includes decongestive exercises, manual lymphatic drainage, compression therapy(either through short stretch bandaging and/or pneumatic device) and exercise. Patients will be evaluated with limb volume, lymphedema index acquired through bioimpedance device, QuickDASH for upper extremity function, hand dynamometer for upper extremity grip strength and CLUE(Breast Cancer-Related Lymphedema of the Upper Extremity standardized clinical evaluation tool) scoring for lymphedema before and after the intervention. The values will be compared in order to show whether there are significant differences between before and after scores, and whether CLUE score is correlated with the other indicators of breast cancer related lymphedema.

NCT ID: NCT04756791 Recruiting - Clinical trials for Mastectomy; Lymphedema

Prospective Comparison of Single-Injection Serratus Anterior Plane Block With Ropivacaine Versus Local Infiltration of Anaesthetic After Breast Surgery

SAPLIA
Start date: June 16, 2021
Phase: Phase 4
Study type: Interventional

To evaluate whether a serratus anterior plane block (SAPB) is more effective than a local infiltration anesthesia (LIA) with an equal dose and same anesthetic performed by the surgeon, as an adjuvant to treat postoperative pain after unilateral mastectomy.

NCT ID: NCT04749342 Completed - Clinical trials for Edema Due to Obstruction of Lymph Vessels or Excision of Lymph Nodes

Complete Decongestive Therapy Versus Compression Bandaging in Advanced Secondary Lymphedema

Start date: March 1, 2019
Phase: N/A
Study type: Interventional

The purpose of this study is to: Find out the efficacy of using complete decongestive physiotherapy on limb volume in advanced secondary upper and lower extremity lymphedema patients. Find out the efficacy of compression bandaging on limb volume in advanced lymphedema patients. This study was conducted to compare between the efficacy of complete decongestive therapy (CDT) and compression bandaging in advanced secondary lower extremity lymphedema.

NCT ID: NCT04724356 Completed - Quality of Life Clinical Trials

Effect of Exercise Mode in Breast Cancer-Related Lymphedema

Lymphedema
Start date: January 15, 2019
Phase: N/A
Study type: Interventional

Gaining a greater understanding of how each exercise mode affects lymphedema, as well as other health-related outcomes will improve exercise prescription guidelines relevant to this specific lymphedema. Therefore, the purpose of this work was to compare the effects of Xbox kinect rehabilitation and resistance exercises on limb volume, symptoms severity, physical function, and quality of life in women with Breast cancer-related lymphedema.

NCT ID: NCT04698707 Completed - Lymphedema Clinical Trials

Role of Supermicrosurgical LVA for Lower Limb Lymphedema

Start date: August 28, 2020
Phase:
Study type: Observational

Vascularized lymph node flap transfer (VLNT) was believed to be the treatment of choice for moderate-to-severe lymphedema. Recent publications have supported the use of supermicrosurgical lymphaticovenous anastomosis (LVA) for treating severe lymphedema. This study hypothesizes whether LVA can be performed on post-VLNT patients seeking further improvement.

NCT ID: NCT04691310 Completed - Clinical trials for Head and Neck Cancer

The Efficacy of Kinesio Taping on Lymphedema Following Head and Neck Cancer Therapy

Start date: December 31, 2020
Phase: N/A
Study type: Interventional

Purpose off the study is investigating to efficacy of kinesio taping on neck lymphedema after the head and neck cancer therapy.

NCT ID: NCT04690439 Recruiting - Breast Cancer Clinical Trials

Photobiomodulation Therapy for the Management of Breast Cancer-related Lymphedema

LymphLight
Start date: February 22, 2021
Phase: N/A
Study type: Interventional

Up to one out of five patients with breast cancer will develop lymphedema in the upper extremity after cancer treatment. Patients with breast cancer-related lymphedema (BCRL) suffer from pain, heaviness, tightness, and a decreased range of motion. Photobiomodulation therapy (PBMT) is a non-invasive therapy based on the application of visible and/or near-infrared light produced by a laser diode or a light-emitting diode. The scientifically proven biologic effects of PBM are improved wound healing, and a reduction in pain, inflammation, and oedema. Therefore, the aim of this study is to evaluate the effectiveness of PBMT on the management of BCRL.

NCT ID: NCT04687956 Recruiting - Breast Cancer Clinical Trials

Primary Surgical Prevention of Breast Cancer-related Lymphedema

LYMPHA
Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Lymphedema refers to edema caused by insufficient drainage of interstitial fluid through the lymphatic circulation system. It occurs mainly in the upper and lower extremities and causes chronic inflammation, and finally fibrous adipose tissue is replaced. In this study, the'LYMPHA' (Lymphatic microsurgical preventing healing approach) procedure, which connects lymphatic vessels drained from the arm to the side branches of the axillary vein, contributes to the prevention of lymphedema in patients undergoing axillary lymph node dissection for breast cancer. Investigator aim to help patients' quality of life by prospectively analyzing the effects and applying them to clinical practice, reducing the incidence of lymphedema.

NCT ID: NCT04665882 Recruiting - Breast Cancer Clinical Trials

Nomogram to Predict Breast Cancer Related Lymphedema

Start date: December 11, 2020
Phase: N/A
Study type: Interventional

It has been hypothesized that damaged arm lymphatic drainage is associated with the arm lymphedema after axillary lymph node dissection (ALND). However, the majority of breast cancer patients with complete ALND has not suffered from arm lymphedema, which appears to be due to the residual arm lymph nodes that has not been removed in the axillary dissection. With the compensation of the residual arm lymph flow above the level of axillary vein, the arm lymphatic drainage could keep balance and remain normal function. This arm lymphedema prediction model that included the protective factor, the proportion of arm lymph flow above the level of axillary vein, allows intraoperative intervention to be performed for the high-risk group. The arm lymphatics of these distinguished patients would be preserved to eliminate the occurrence of arm lymphedema in this study.